Trial | NCT00913419  Report issue

Title

To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets
Bioavailability of Cyclobenzaprine HCl Tablets

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    cyclobenzaprine ...

  • Study Participants

    30
To demonstrate the relative bioavailability of Cyclobenzaprine HCl tablets.
Study Started
Nov 30
1988
Primary Completion
Dec 31
1988
Study Completion
Dec 31
1988
Last Update
Mar 28
2017

Drug Cyclobenzaprine HCl Tablets 10 mg, Cord Laboratories

Drug Cyclobenzaprine HCl Tablets 10 mg, Merck Sharp & Dohme

1 Experimental

Cyclobenzaprine HCl Tablets 10 mg, Cord Laboratories

2 Active Comparator

Cyclobenzaprine HCl Tablets 10 mg, Merck Sharp & Dohme

Criteria 

Inclusion Criteria:

No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion Criteria:

Positive test results for HIV or hepatitis B or C.
Treatment for drug or alcohol dependence.
No Results Posted